Fortrea Share Price (NASDAQ: FTRE)

$9.01

▲

0.03

(0.33%)

Live

Last updated on August 28, 2025 at 12:38 am IST

$₹

Check the interactive Fortrea Stock chart to analyse performance

Fortrea stock performance

as on August 28, 2025 at 12:38 am IST

Today's Low:$8.55
Today's High:$9.02
$9.01
5.11%
Downside
Day's Volatility :5.16%
Upside
0.06%
52 Weeks Low:$3.97
52 Weeks High:$25.28
$9.01
55.94%
Downside
52 Weeks Volatility :84.3%
Upside
64.36%

Fortrea Stock Returns

Period	Fortrea Holdings Inc	Index (Russel 2000)
3 Months	114.59%	0.0%
6 Months	-40.52%	0.0%
1 Year	-60.71%	0.0%
3 Years	-75.65%	-6.9%

Fortrea Holdings Inc Key Stats

Check Fortrea key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$8.98
Open	$8.88
Today's High	$9.08
Today's Low	$8.55
Market Capitalization	$804.5M
Today's Volume	$4.3M
52 Week High	$25.28
52 Week Low	$3.97
Revenue TTM	$2.7B
EBITDA	$8.2M
Earnings Per Share (EPS)	$-11.39
Profit Margin	-37.57%
Quarterly Earnings Growth YOY	-0.57%
Return On Equity TTM	-100.49%

Stock Returns calculator for Fortrea Stock including INR - Dollar returns

The Fortrea stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Fortrea investment value today

Current value as on today

₹44,139

Returns

₹55,861

(-55.86%)

Returns from Fortrea Stock

₹60,534 (-60.53%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Fortrea Stock

19%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Fortrea Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Fortrea Stock

Rating

Trend

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Fortrea(by analysts ranked 0 to 5 stars)

Fortrea Share Price Target

What analysts predicted

Downside of 17.47%

Target:

$7.44

Current:

$9.01

Fortrea share price target is $7.44, a slight Downside of 17.47% compared to current price of $9.01 as per analysts' prediction.

Fortrea Stock Insights

Price Movement
In the last 7 days, FTRE stock has moved up by 16.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 651.3M → 710.3M (in $), with an average increase of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -562.9M → -374.9M (in $), with an average increase of 50.2% per quarter
FTRE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 121.7%
Price to Sales
ForFTRE every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.

Fortrea Holdings Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

	FY20	Y/Y Change
Revenue	$2.6B	-
Net Income	$-359.2M	-
Net Profit Margin	-13.92%	-

	FY21	Y/Y Change
Revenue	$3.1B	↑ 18.49%
Net Income	$98.0M	↓ 127.28%
Net Profit Margin	3.21%	↑ 17.13%

	FY22	Y/Y Change
Revenue	$3.1B	↑ 1.26%
Net Income	$192.9M	↑ 96.84%
Net Profit Margin	6.23%	↑ 3.02%

	FY23	Y/Y Change
Revenue	$2.8B	↓ 8.19%
Net Income	$-25.2M	↓ 113.06%
Net Profit Margin	-0.89%	↓ 7.12%

	FY24	Y/Y Change
Revenue	$2.7B	↓ 5.14%
Net Income	$-328.5M	↑ 1203.57%
Net Profit Margin	-12.18%	↓ 11.29%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$662.1M	↓ 14.61%
Net Income	$-101.0M	↑ 180.56%
Net Profit Margin	-15.25%	↓ 10.61%

	Q2 FY24	Q/Q Change
Revenue	$662.4M	↑ 0.05%
Net Income	$-138.4M	↑ 37.03%
Net Profit Margin	-20.89%	↓ 5.64%

	Q3 FY24	Q/Q Change
Revenue	$674.9M	↑ 1.89%
Net Income	$-27.9M	↓ 79.84%
Net Profit Margin	-4.13%	↑ 16.76%

	Q4 FY24	Q/Q Change
Revenue	$697.0M	↑ 3.27%
Net Income	$-61.2M	↑ 119.35%
Net Profit Margin	-8.78%	↓ 4.65%

	Q1 FY25	Q/Q Change
Revenue	$651.3M	↓ 6.56%
Net Income	$-562.9M	↑ 819.77%
Net Profit Margin	-86.43%	↓ 77.65%

	Q2 FY25	Q/Q Change
Revenue	$710.3M	↑ 9.06%
Net Income	$-374.9M	↓ 33.4%
Net Profit Margin	-52.78%	↑ 33.65%

FY20

FY21

FY22

FY23

FY24

	FY20	Y/Y Change
Profit	$489.1M	-

	FY21	Y/Y Change
Profit	$604.4M	↑ 23.57%

	FY22	Y/Y Change
Profit	$621.7M	↑ 2.86%

	FY23	Y/Y Change
Profit	$590.6M	↓ 5.0%

	FY24	Y/Y Change
Profit	$534.2M	↓ 9.55%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$107.9M	↓ 9.86%

	Q2 FY24	Q/Q Change
Profit	$137.1M	↑ 27.06%

	Q3 FY24	Q/Q Change
Profit	$148.3M	↑ 8.17%

	Q4 FY24	Q/Q Change
Profit	$140.9M	↓ 4.99%

	Q1 FY25	Q/Q Change
Profit	$116.5M	↓ 17.32%

	Q2 FY25	Q/Q Change
Profit	$113.9M	↓ 2.23%

FY20

FY21

FY22

FY23

FY24

	FY20	Y/Y Change
Operating Cash Flow	$200.9M	-
Investing Cash Flow	$-161.2M	-
Financing Cash Flow	$-33.1M	-

	FY21	Y/Y Change
Operating Cash Flow	$169.8M	↓ 15.48%
Investing Cash Flow	$-26.2M	↓ 83.75%
Financing Cash Flow	$-128.5M	↑ 288.22%

	FY22	Y/Y Change
Operating Cash Flow	$87.5M	↓ 48.47%
Investing Cash Flow	$-54.0M	↑ 106.11%
Financing Cash Flow	$-8.7M	↓ 93.23%

	FY23	Y/Y Change
Operating Cash Flow	$167.4M	↑ 91.31%
Investing Cash Flow	$-31.8M	↓ 41.11%
Financing Cash Flow	$-140.8M	↑ 1518.39%

	FY24	Y/Y Change
Operating Cash Flow	$262.8M	↑ 56.99%
Investing Cash Flow	$251.6M	↓ 891.19%
Financing Cash Flow	$-497.8M	↑ 253.55%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-25.6M	↓ 306.45%
Investing Cash Flow	$-9.2M	↑ 2.22%
Financing Cash Flow	$21.3M	↓ 563.04%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$273.7M	↓ 1169.14%
Investing Cash Flow	$265.4M	↓ 2984.78%
Financing Cash Flow	$-504.0M	↓ 2466.2%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.4M	↓ 100.88%
Investing Cash Flow	$-8.1M	↓ 103.05%
Financing Cash Flow	$-14.0M	↓ 97.22%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$17.1M	↓ 812.5%
Investing Cash Flow	$3.5M	↓ 143.21%
Financing Cash Flow	$-1.1M	↓ 92.14%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-124.2M	↓ 826.32%
Investing Cash Flow	$16.1M	↑ 360.0%
Financing Cash Flow	$88.4M	↓ 8136.36%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$21.8M	↓ 117.55%
Investing Cash Flow	$-7.5M	↓ 146.58%
Financing Cash Flow	$-39.0M	↓ 144.12%

Fortrea Technicals Summary

Sell

Neutral

Buy

Fortrea is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Fortrea Holdings Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fortrea Holdings Inc	30.57%	-40.52%	-60.71%	-75.65%	-75.65%
Regeneron Pharmaceuticals, Inc.	5.16%	-16.9%	-51.12%	-0.89%	-2.51%
Beone Medicines Ltd	4.54%	18.87%	52.28%	84.02%	26.72%
Vertex Pharmaceuticals Incorporated	-16.02%	-19.22%	-19.42%	37.43%	43.36%
Alnylam Pharmaceuticals, Inc.	38.9%	84.99%	60.96%	115.82%	243.29%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fortrea Holdings Inc	467.67	NA	NA	0.54	-1.0	-0.01	NA	6.49
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.21	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.29	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.64	27.64	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fortrea Holdings Inc	Buy	$804.5M	-75.65%	467.67	-37.57%
Regeneron Pharmaceuticals, Inc.	Buy	$62.5B	-2.51%	14.86	31.37%
Beone Medicines Ltd	NA	$38.3B	26.72%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$99.7B	43.36%	27.64	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$58.2B	243.29%	NA	-12.96%

About Fortrea Holdings Inc

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Organization	Fortrea
Employees	14500
CEO	Mr. Anshul Thakral
Industry	Miscellaneous

Key Management of Fortrea Holdings Inc

Name	Title
Ms. Jill McConnell	Chief Financial Officer
Mr. Mark A. Morais	COO & President of Clinical Services
Mr. Anshul Thakral	CEO & Director
Mr. Drayton Virkler	President & Chief Commercial Officer
Mr. Robert Parks	Chief Accounting Officer
Mr. Alejandro Martinez Galindo	Chief Information Officer
Mr. Dave Cooper	Chief Administrative Officer
Ms. Tracy H. Krumme	Senior VP of Investor Relations
Mr. J. Stillman Hanson J.D.	General Counsel & Corporate Secretary
Ms. Hima B. Inguva	Head of Corporate Development

Important FAQs about investing in FTRE Stock from India :

What is Fortrea share price today?

Fortrea share price today is $9.01 as on August 28, 2025 at 12:38 am IST. Fortrea share today touched a day high of $9.02 and a low of $8.55.

What is the 52 week high and 52 week low for Fortrea share?

Fortrea share touched a 52 week high of $25.28 and a 52 week low of $3.97. Fortrea stock price today i.e. August 28, 2025 at 12:38 am IST is trending at $9.01, lower by 64.36% versus the 52 week high.

How to invest in Fortrea Stock (FTRE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fortrea on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fortrea Shares that will get you 0.1665 shares as per Fortrea share price of $9.01 per share as on August 28, 2025 at 12:38 am IST.

What is the minimum amount required to buy Fortrea Stock (FTRE) from India?

Indian investors can start investing in Fortrea (FTRE) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Fortrea stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Fortrea share’s latest price of $9.01 as on August 28, 2025 at 12:38 am IST, you will get 1.1099 shares of Fortrea. Learn more about fractional shares .

What are the returns that Fortrea has given to Indian investors in the last 5 years?

Fortrea stock has given -75.65% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?